HOME >> MEDICINE >> NEWS
NIAID awards $4 million to develop anti-radiation treatments

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has issued five awards totaling $4 million to fund the development of products that eliminate radioactive materials from the human body following radiological or nuclear exposure. The awards, which were granted under Project Bioshield authorities, complement NIAID's other medical countermeasure efforts to create safe and effective products of this type.

"These new grants will help identify new drug candidates that could be acquired by the strategic national stockpile of medical countermeasures, which is available to the public after a terrorist or nuclear attack or accidental radioactive exposure," says NIAID Director Anthony S. Fauci, M.D.

In the event of an attack by a nuclear explosive device or radiological "dirty bomb," individuals potentially could inhale, ingest or absorb through their skin radioactive atoms called radionuclides. Depending on the type of radionuclide that a person is exposed to, the particles may be excreted from the body or enter bones, organs or other tissues, which could have significant adverse health consequences. Through an initiative announced in 2005, NIAID already is working to speed the development of a series of products that can bind (chelate) internally with the radionuclides and eliminate (decorporate) them from the body. Radionuclide decorporation products currently are available in the strategic national stockpile, but NIAID is focusing on expanding the product pool, creating new treatments capable of eliminating a wider range of radionuclides, developing products that can eliminate radioactive material faster and in greater amounts; and developing products in formulations that could be distributed more easily in a mass casualty situation.

NIAID has awarded five grants totaling up to $4 million to fund work for a period of 18 months. The following principal investigators and univ
'"/>

Contact: Kathy Stover
kstover@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
25-Sep-2006


Page: 1 2

Related medicine news :

1. NIAID releases MDR/XDR Tuberculosis research agenda
2. NIAID DNA vaccine for H5N1 avian influenza enters human trial
3. NIAID media availability: Examining genetic variability of malaria parasite offers insight
4. Partnership between NIAID and Sequella yields promising new TB drug for clinical testing
5. NIAID announces leadership for newly restructured HIV/AIDS clinical trials networks
6. NIAID study finds higher dose of flu vaccine improves immune response in the elderly
7. NIAID media availability: New study describes key protein from highly pathogenic H5N1 avian flu virus and how it might mutate
8. NIAID media availability: Understanding influenza infection
9. NIAID researchers show how promising TB drug works
10. NIAID awards $47 million to develop medical countermeasures against radiological, nuclear threats
11. NIAID launches first Phase II trial of a global HIV/AIDS vaccine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/19/2019)... ... 2019 , ... Residents in long-term-care nursing facilities were prescribed fewer medications when ... to a study of U.S. men and women led by the staff at ... Institute (BRI) . The quality assurance study examined the high number of prescriptions ordered ...
(Date:4/18/2019)... ... April 18, 2019 , ... BNCT ... to deliver targeted radiation to cancer cells while sparing surrounding healthy tissue. NTI’s ... platforms. Engineered from the ground up for high reliability and ease of maintenance, ...
(Date:4/18/2019)... ... 18, 2019 , ... She went from learning disabled to honor roll – ... Cheryl Reilly. Those “goofy tests,” performed by Deborah Zelinsky, O.D. , founder of ... had such narrow range of visual awareness, she could only see what was directly ...
(Date:4/17/2019)... , ... April 17, 2019 , ... ... advice. However, recently, this reluctance appears to be changing. Whether because of demographic ... at least, probe their healthcare providers advice. , In the past, efforts to ...
(Date:4/17/2019)... ... , ... Fertility Centers of Illinois will recognize ... unite millions of Americans aiming to remove the stigmas and barriers associated with ... of Illinois is offering seven free physician-led webinars and free Fertility Awareness Checkups, ...
Breaking Medicine News(10 mins):
(Date:4/18/2019)... ... April 18, 2019 , ... Bioclinica®, a leading provider of ... development of medical therapies, announced today that it has assembled a team of ... nonalcoholic steatohepatitis (NASH), to help sponsors develop therapeutics using medical imaging and other ...
(Date:4/18/2019)... ... April 18, 2019 , ... Global Lyme Alliance ... research, education, and awareness, and Ranger Ready Repellents, a new EPA-registered brand ... of tick-bite prevention, including the proper use of repellents, to safeguard the public ...
(Date:4/17/2019)... ... , ... Salt Lake Community College has named Jay K. Francis ... at SLCC’s May 3 Commencement at the Maverik Center, 3200 S. Decker Lake Drive, ... Miller Family Philanthropy. Richards is president and CEO of SelectHealth. , Francis studied business ...
Breaking Medicine Technology:
Cached News: